Clinical Trial Results:
Randomized phase III trial comparing early treatment with
fludarabine, cyclophosphamide + rituximab versus deferred
treatment in untreated Binet stage A patients
with high risk of progression
CLL 7 protocol of the GCLLSG and FCGCLL
Summary
|
|
EudraCT number |
2005-003018-14 |
Trial protocol |
AT CZ |
Global completion date |
01 Jan 2013
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v2(current) |
This version publication date |
24 Aug 2022
|
First version publication date |
08 Mar 2022
|
Other versions |
v1 |
Version creation reason |
|
Summary report(s) |
Summary Attachment |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.